Filed under: MLB PEDs, Sports Business and Media
Congressional hearings that have put the likes of Mark McGwire, Sammy Sosa and Roger Clemens in the crosshairs appear to be far less likely to occur as the Republicans seized control of the House of Representatives this week.Rep. Darrell Issa, the incoming chairman of the House subcommittee that called the iconic hearings into steroid use in baseball, has no interest in exploring performance-enhancing drugs in sports, his spokesman told FanHouse.
"I think it's clear to the American people that jobs and the economy are more important than steroids in baseball," Frederick Hill said. "It would be unlikely that the Oversight Committee will turn its focus to steroids or any other performance-enhancing substances. We are more concerned about stimulus oversight, taxpayer money that went into TARP (Troubled Asset Relief Program) and health care laws."
The House Committee on Oversight and Government Reform's first hearing on the subject came in the wake of the Bay Area Lab Co-Operative (BALCO) scandal that linked several athletes to steroids, human growth hormones and other performance-enhancing drugs. While the 2005 hearing was probably best known for McGwire's refusal to answer questions and Rafael Palmeiro's denials of using drugs months before he tested positive for steroids, anti-drug crusaders applauded the panel's efforts that pressured Major League Baseball to impose more strict testing standards and led to an outside investigation headed by former Senator George Mitchell.
Permalink | Email this | Linking Blogs | Comments
Source: http://mlb.fanhouse.com/2010/11/05/new-congress-less-likely-to-tackle-drugs-in-sports/
sports club la east side fantasy baseball baseball america top prospects 2011
No comments:
Post a Comment